- Patent Title: Dynamin 2 inhibitor for the treatment of centronuclear myopathies
-
Application No.: US15030127Application Date: 2014-10-20
-
Publication No.: US10647986B2Publication Date: 2020-05-12
- Inventor: Jocelyn Laporte , Belinda Cowling , Hichem Tasfaout
- Applicant: UNIVERSITE DE STRASBOURG , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Applicant Address: FR Strasbourg FR Paris FR Paris
- Assignee: UNIVERSITE DE STRASBOURG,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee: UNIVERSITE DE STRASBOURG,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Current Assignee Address: FR Strasbourg FR Paris FR Paris
- Agency: Saliwanchik, Lloyd & Eisenchenk
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@114e10d1
- International Application: PCT/EP2014/072466 WO 20141020
- International Announcement: WO2015/055859 WO 20150423
- Main IPC: C12N15/113
- IPC: C12N15/113 ; G01N33/50
Abstract:
The present disclosure relates to an inhibitor of Dynamin 2 for use in the treatment of centronuclear myopathies. The present disclosure relates to pharmaceutical compositions containing Dynamin 2 inhibitor and to their use for the treatment of centronuclear myopathies. It also deals with a method for identifying or screening molecules useful in the treatment of a centronuclear myopathy.
Public/Granted literature
- US20160264976A1 DYNAMIN 2 INHIBITOR FOR THE TREATMENT OF CENTRONUCLEAR MYOPATHIES Public/Granted day:2016-09-15
Information query
IPC分类:
